Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. SNPS

Go back to Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
(NASDAQ: AKTX) Delayed: 9.01 -0.09 (0.99%)
Previous Close $9.10    52 Week High $19.75 
Open $9.60    52 Week Low $7.63 
Day High $9.60    P/E N/A 
Day Low $8.75    EPS $0.00 
Volume 54,077